Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOption exercise — administrative, little informational value
$23K reported value · new position
Disclosed 0 business days after execution (deadline: 2)
Routine: 14 prior trades recorded in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 34 | Cardoza GeorgeChief Financial Officer | Open-market purchase | BUY | $141K 20.0K sh | Nov 9, 2026 traded Nov 6, 2026 | |
| 44 | Muken RossDirector, Chief Executive Officer | Open-market purchase | BUY | $137K 20.0K sh | Nov 9, 2026 traded Nov 6, 2026 | |
| 13 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $29K 4,000 sh | Oct 14, 2026 traded Oct 13, 2026 | |
| 13 | Menu PhilippeChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $36K 5,000 sh | Oct 14, 2026 traded Oct 12, 2026 | |
| 16 | Camblong JurgiDirector, Executive Chairman | Open-market sale · 10b5-1 plan | SELL | $62K 8,500 sh | Oct 14, 2026 traded Oct 12, 2026 | |
| 16 | Muken RossDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $80K 9,838 sh | Oct 7, 2026 traded Oct 5, 2026 | |
| 19 | Camblong JurgiDirector, Executive Chairman | Open-market sale · 10b5-1 plan | SELL | $327K 40.2K sh | Oct 7, 2026 traded Oct 5, 2026 | |
| 29 | Puylaert KevinChief Sales Officer | Open-market sale | SELL | $246 31 sh | Oct 7, 2026 traded Oct 5, 2026 | |
| 13 | Valente ManuelaChief People Officer | Open-market sale · 10b5-1 plan | SELL | $34K 4,240 sh | Oct 7, 2026 traded Oct 5, 2026 | |
| 16 | Menu PhilippeChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $60K 7,394 sh | Oct 7, 2026 traded Oct 5, 2026 | |
| 13 | Verma AbhimanyuChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $43K 5,284 sh | Oct 7, 2026 traded Oct 5, 2026 | |
| 16 | Van Well DaanChief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $50K 6,168 sh | Oct 7, 2026 traded Oct 5, 2026 | |
| 29 | Puylaert KevinChief Sales Officer | Open-market sale | SELL | $1,491 185 sh | Oct 7, 2026 traded Oct 5, 2026 | |
| 16 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $60K 7,394 sh | Oct 7, 2026 traded Oct 5, 2026 | |
| 13 | Cardoza GeorgeChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $13K 1,592 sh | Oct 7, 2026 traded Oct 5, 2026 | |
| 13 | Muken RossDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $3,515 422 sh | Sep 22, 2026 traded Sep 21, 2026 | |
| 13 | Cardoza GeorgeChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $6,447 774 sh | Sep 22, 2026 traded Sep 21, 2026 | |
| 13 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $32K 4,000 sh | Sep 16, 2026 traded Sep 14, 2026 | |
| 29 | Menu PhilippeChief Medical Officer | Open-market sale | SELL | $39K 5,000 sh | Sep 16, 2026 traded Sep 14, 2026 | |
| 16 | Camblong JurgiDirector, Executive Chairman | Open-market sale · 10b5-1 plan | SELL | $65K 8,500 sh | Sep 14, 2026 traded Sep 10, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $22,960
Xu Zhenyu filed this Form 4 reporting a option exercise of SOPH on Aug 7, 2026. It became public on Aug 7, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.